investment.com

BIO-TECHNE Corp — insider transactions

62 transactions on record · TECH · CIK 842023

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
62
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
6
Bought, 3m
$0
Sold, 3m
$11.9M
Median disclosure lag
3.0 d
trade date to filing date
Largest single trade, 24m
$3.7M
2026-07-29
Director share, 12m
33.9%
of transactions where role is stated
Current run
62 sells
consecutive same-direction transactions
Net 3m flow
-$11.9M
purchases minus sales
Total on record
62

Transactions

62 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-08-192026-08-172Crouse Steven C.Spatial BiGrant or award14,140$0.00—filing
2026-08-192026-08-172Geist WilliamPRESIDENT, PROTEIN SCIENCESGrant or award14,762$0.00—filing
2026-08-192026-08-172Hippel JamesCFOGrant or award36,459$0.00—filing
2026-08-192026-08-172Kelderman KimDirector, Chief Executive OfficerGrant or award57,590$0.00—filing
2026-08-192026-08-172Geist WilliamPRESIDENT, PROTEIN SCIENCESGrant or award23,985$0.00—filing
2026-08-192026-08-172Herr Amy E.DirectorGrant or award1,381$0.00—filing
2026-08-192026-08-172Hippel JamesCFOGrant or award22,438$0.00—filing
2026-08-192026-08-172Bohnen ShaneSVP - General CounselGrant or award18,432$0.00—filing
2026-08-192026-08-172Crouse Steven C.Spatial BiGrant or award8,702$0.00—filing
2026-08-192026-08-172Kelderman KimDirector, Chief Executive OfficerGrant or award93,582$0.00—filing
2026-08-192026-08-172Bohnen ShaneSVP - General CounselGrant or award11,344$0.00—filing
2026-08-182026-08-153Herr Amy E.DirectorShares withheld for tax213$72.40$15.4Kfiling
2026-08-182026-08-153Herr Amy E.DirectorExercise of derivative311$0.00—filing
2026-08-182026-08-153Herr Amy E.DirectorExercise of derivative118$0.00—filing
2026-08-182026-08-153Crouse Steven C.Spatial BiExercise of derivative5,423$0.00—filing
2026-08-182026-08-153Crouse Steven C.Spatial BiExercise of derivative1,868$0.00—filing
2026-08-182026-08-153Herr Amy E.DirectorExercise of derivative589$0.00—filing
2026-08-182026-08-153Herr Amy E.DirectorExercise of derivative160$0.00—filing
2026-08-182026-08-153Crouse Steven C.Spatial BiShares withheld for tax1,947$72.40$141Kfiling
2026-08-182026-08-153Crouse Steven C.Spatial BiExercise of derivative2,176$0.00—filing
2026-08-182026-08-153Bohnen ShaneSVP - General CounselExercise of derivative4,350$0.00—filing
2026-08-182026-08-153Bohnen ShaneSVP - General CounselDisposition to issuer12,117$0.00—filing
2026-08-182026-08-153Crouse Steven C.Spatial BiExercise of derivative1,379$0.00—filing
2026-08-182026-08-153Bohnen ShaneSVP - General CounselShares withheld for tax1,343$72.40$97.2Kfiling
2026-08-182026-08-153Bohnen ShaneSVP - General CounselExercise of derivative300$0.00—filing
2026-08-182026-08-153Bohnen ShaneSVP - General CounselExercise of derivative2,332$0.00—filing
2026-08-182026-08-153Geist WilliamPRESIDENT, PROTEIN SCIENCESExercise of derivative567$0.00—filing
2026-08-182026-08-153Geist WilliamPRESIDENT, PROTEIN SCIENCESExercise of derivative2,623$0.00—filing
2026-08-182026-08-153Hippel JamesCFOExercise of derivative866$0.00—filing
2026-08-182026-08-153Hippel JamesCFOExercise of derivative4,010$0.00—filing
2026-08-182026-08-153Kelderman KimDirector, Chief Executive OfficerExercise of derivative554$0.00—filing
2026-08-182026-08-153Kelderman KimDirector, Chief Executive OfficerExercise of derivative588$0.00—filing
2026-08-182026-08-153Kelderman KimDirector, Chief Executive OfficerExercise of derivative8,543$0.00—filing
2026-08-182026-08-153Bohnen ShaneSVP - General CounselExercise of derivative49$0.00—filing
2026-08-182026-08-153Bohnen ShaneSVP - General CounselDisposition to issuer4,502$0.00—filing
2026-08-182026-08-153Geist WilliamPRESIDENT, PROTEIN SCIENCESExercise of derivative6,416$0.00—filing
2026-08-182026-08-153Geist WilliamPRESIDENT, PROTEIN SCIENCESDisposition to issuer8,507$0.00—filing
2026-08-182026-08-153Geist WilliamPRESIDENT, PROTEIN SCIENCESExercise of derivative3,226$0.00—filing
2026-08-182026-08-153Hippel JamesCFOExercise of derivative9,779$0.00—filing
2026-08-182026-08-153Hippel JamesCFODisposition to issuer12,999$0.00—filing
2026-08-182026-08-153Hippel JamesCFOExercise of derivative4,903$0.00—filing
2026-08-182026-08-153Kelderman KimDirector, Chief Executive OfficerExercise of derivative21,470$0.00—filing
2026-08-182026-08-153Kelderman KimDirector, Chief Executive OfficerDisposition to issuer8,319$0.00—filing
2026-08-182026-08-153Kelderman KimDirector, Chief Executive OfficerDisposition to issuer8,835$0.00—filing
2026-08-182026-08-153Bohnen ShaneSVP - General CounselExercise of derivative1,669$0.00—filing
2026-08-182026-08-153Geist WilliamPRESIDENT, PROTEIN SCIENCESShares withheld for tax1,976$72.40$143.1Kfiling
2026-08-182026-08-153Geist WilliamPRESIDENT, PROTEIN SCIENCESDisposition to issuer22,898$0.00—filing
2026-08-182026-08-153Hippel JamesCFOShares withheld for tax4,310$72.40$312Kfiling
2026-08-182026-08-153Hippel JamesCFODisposition to issuer34,982$0.00—filing
2026-08-182026-08-153Kelderman KimDirector, Chief Executive OfficerShares withheld for tax10,821$72.40$783.4Kfiling
2026-08-182026-08-153Kelderman KimDirector, Chief Executive OfficerDisposition to issuer22,389$0.00—filing
2026-08-182026-08-153Kelderman KimDirector, Chief Executive OfficerDisposition to issuer24,324$0.00—filing
2026-08-182026-08-153Kelderman KimDirector, Chief Executive OfficerExercise of derivative11,785$0.00—filing
2026-07-312026-07-292Hippel JamesCFOExercise of derivative62,068$47.60$3Mfiling
2026-07-312026-07-292Hippel JamesCFOExercise of derivative62,068$0.00—filing
2026-07-312026-07-292Hippel JamesCFOShares withheld for tax51,024$72.03$3.7Mfiling
2026-07-302026-07-282Kelderman KimDirector, Chief Executive OfficerExercise of derivative35,000$47.60$1.7Mfiling
2026-07-302026-07-282Kelderman KimDirector, Chief Executive OfficerShares withheld for tax28,686$72.07$2.1Mfiling
2026-07-302026-07-282Kelderman KimDirector, Chief Executive OfficerExercise of derivative35,000$0.00—filing
2026-07-272026-07-234Bohnen ShaneSVP - General CounselExercise of derivative448$47.60$21.3Kfiling
2026-07-272026-07-234Bohnen ShaneSVP - General CounselExercise of derivative448$0.00—filing
2026-07-272026-07-234Bohnen ShaneSVP - General CounselShares withheld for tax344$71.77$24.7Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

BIO-TECHNE Corp insider transactions — 62 filings on record — investment.com